Physician profile
Srinadh Komanduri
NPI 1952342339
$104,080.87
in general payments reported to CMS, 2019-2025
23 companies · $20K in 2025
The $20K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $1,275 · 2021: $4,714 · 2022: $11K · 2023: $2,441 · 2024: $34K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Consulting Fee: $22K · Travel and Lodging: $4,130 · Food and Beverage: $3,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,500.00 |
| Consulting Fee | $21,575.00 |
| Travel and Lodging | $4,130.49 |
| Food and Beverage | $3,035.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $70,746.57 | 2019-2025 | Exalt Model D, Spyglass Discover, Apollo Esg System |
| Olympus Corporation | $15,354.21 | 2025 | Evis Exera III Colonovideoscope |
| Medtronic, INC. | $3,791.97 | 2021-2025 | Barrx, Gi Genius, Pillcam |
| Covidien LP | $2,980.00 | 2019 | |
| Ethicon INC. | $2,020.00 | 2023-2024 | |
| Medical Device Business Services, INC. | $1,663.43 | 2019-2024 | |
| Olympus Corporation of The Americas | $1,447.49 | 2024-2025 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope, Endoclot Sis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,250.00 | 2019 | |
| US Endoscopy | $1,250.00 | 2025 | |
| Endogastric Solutions, INC | $1,050.00 | 2023 | Esophyx |
| Gi Supply, INC. | $800.00 | 2019 | |
| Cook Medical LLC | $672.29 | 2021-2024 | Hemospray |
| Pentax of America, INC. | $444.12 | 2020-2023 | C2 Cryoballoon |
| Olympus America INC. | $228.26 | 2021-2025 | |
| Fujifilm Healthcare Americas Corporation | $101.50 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $99.65 | 2021-2025 | |
| Conmed Corporation | $57.05 | 2022-2023 | Conmed Biliary |
| Mauna Kea Technologies, INC. | $37.18 | 2023 | |
| Phathom Pharmaceuticals, INC. | $32.25 | 2024 | Voquezna |
| Creo Medical INC. | $20.50 | 2021 | |
| Exact Sciences Corporation | $17.26 | 2024 | |
| Acacia Pharma INC | $17.14 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinadh Komanduri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.